# A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function

> **NCT03657446** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Clazosentan
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT03657446
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-18
- **Primary completion:** 2018-10-26
- **Final completion:** 2018-10-26
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03657446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03657446, "A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03657446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*